Publication: The Rotterdam Study: 2018 update on objectives, design and main results
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Netherlands
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Ikram, M. A., G. G. O. Brusselle, S. D. Murad, C. M. van Duijn, O. H. Franco, A. Goedegebure, C. C. W. Klaver, et al. 2017. “The Rotterdam Study: 2018 update on objectives, design and main results.” European Journal of Epidemiology 32 (9): 807-850. doi:10.1007/s10654-017-0321-4. http://dx.doi.org/10.1007/s10654-017-0321-4.
Research Data
Abstract
The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. Since 2016, the cohort is being expanded by persons aged 40 years and over. The findings of the Rotterdam Study have been presented in over 1500 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.
Description
Other Available Sources
Keywords
Biomarkers, Cardiovascular diseases, Cohort study, Dermatological diseases, Endocrine diseases, Epidemiologic methods, Genetic epidemiology, Liver diseases, Neurological diseases, Oncology, Ophthalmic diseases, Otolaryngological diseases, Pharmacoepidemiology, Renal diseases, Psychiatric diseases, Respiratory diseases
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service